It is appropriate to evaluate newborn sibs of a proband so that morbidity and mortality can be reduced by early diagnosis and treatment. Evaluations can include:

Molecular genetic testing if the pathogenic variants in the family are known;

Assay of ADA catalytic activity if the pathogenic variants in the family are not known.

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.
